Referrals for Patients with Polycythemia Vera

Ruben A. Mesa, MD

Video Categories: Polycythemia Vera

Dr. Mesa describes why patients with PV who have a broad and heterogeneous course should seek a referral from a specialty center.

Supported through funding from Incyte
January 16, 2019

Navigating the CMS 14-Day Rule in Biomarker Testing

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.

January 13, 2015

Benefits of Breast Cancer Index

Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.